Treatment outcome | RLAI | FGAI | P value |
---|---|---|---|
Abnormal movement | |||
AIMS score completed (n (%)) | 36 (51.4) | 61 (59.8) | 0.28 |
Mean AIMS score | 1.83 | 3.25 | 0.25 |
Proportion of patients with TD (n (%)) | 1 (1.4) | 5 (4.9) | 0.40 |
SAS score completed | 33 (47.1) | 54 (52.9) | 0.45 |
Mean SAS score | 2.82 | 4.85 | 0.28 |
Proportion of patients with EPS | 12 (17.0) | 54 (52.9) | <0.001 |
Side effects of therapy (n (%)) | |||
Patients reporting side effects | 7 (10.0) | 17 (16.7) | 0.21 |
EPS | 1 (14.3) | 3 (17.6) | |
Akathesia | 1 (14.3) | 2 (11.8) | |
Weight gain | 2 (28.6) | 2 (11.8) | |
Tremor | 0 (0) | 4 (23.5) | |
Galactorrhea | 1 (14.3) | 0 (0) | |
Other† | 2 (28.6) | 6 (35.5) |